Briefs: Autonomy signs up Xerox; Antenova antenna in mass production in Korea; Meldex appoints new chairman, exec director

Autonomy Corporation plc, provider of infrastructure software for the enterprise, said Xerox Corporation has entered into an OEM agreement with the company. The new license will allow Xerox to integrate Autonomy's Intelligent Data Operating Layer (IDOL) technology into its DocuShare enterprise content management (ECM) platform.

Xerox DocuShare users will get enhanced search performance with higher volumes of content, as IDOL can support millions of documents in all file formats, and scales to support the largest enterprise-wide and portal deployments in the world. The IDOL server also significantly eases search index maintenance, historically a time-consuming and expensive process. The server will be integrated into existing DocuShare accounts worldwide, and into all future product releases.

The company, the largest high tech by market capitalisation HQed in Cambridge - it's worth just over £2 billion, will release financial results for the year ended December tomorrow.

&

Antenova Ltd, the integrated antenna and RF software firm, said its high performance seven-band mobile broadband antenna is in mass production in the lightest notebook computer in its 13.3-inch LCD class from a leading Korean consumer electronics company.

In addition to 3G cellular mobile broadband capability, Antenova's full diversity antenna provides dual-band Wi-Fi connectivity.

&

Specialty pharma and healthcare firm Meldex International plc appointed Gary Cressman Executive Chairman and Barry Muncaster an executive director.

Jim Murray and Stewart Adkins have resigned as directors.

The Board said in a statement that it is carrying out a review of business activities and operations and will provide an interim report by 24th January. Its shares were suspended from AIM last month pending this review. It was worth around £16.5m at the time.

Mr Cressman, aged 44, has been a director of Bridge Asset Management LLP, Argo Capital Management Ltd and G2 Capital. He has a beneficial interest in 5.6m shares in Meldex.

Mr Muncaster, aged 63, has been a director of several companies, including Hereward Innovation Centre Ltd, Cyan Holdings Ltd, Aquisitek Ltd and Birmont plc. He has a beneficial interest in 16.4m shares through his interest in Aquisitek, where is Chairman and CEO.

 



Previous articles
Autonomy soars as unstructured information issues go 'prime time'
Next generation medical diagnostics closer after SmartBead, FingerPrint merger
Cybit board recommends £23m cash offer from Francisco Partners
Cambridge Broadband raises $22.5m; eyes geographic expansion
Abcam continues strong run of success with sales, profits up 50% in 07/08
Briefs: Autonomy releases Social Media Analysis tool; new chips from CSR
Domino Printing records good 1H growth; sees more ahead
Alps Electric scores Cambridge Uni licence for novel holographic projectors
Enval secures seed funding for breakthrough recycling technology
Silicon Fen pioneers Cambridge Consultants celebrate 50 years
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • Intercytex


Paul Kemp BSc, PhD
Founder and Chief Scientific Officer


Intercytex is an emerging healthcare developer of cell therapy products for the woundcare and aesthetic medicine markets. It is using its proprietary expertise in cell therapy to develop products that harness the innate ability of human cells to regenerate and repair the body. Intercytex commenced

[Intercytex's profile]


Top20 Index




Currently: 130.81

Best Deal Mortgages
If debt is becoming a problem, click here for the best deal mortgages.

marcusevans
Marcus Evans aims to deliver all the info and tools you need in order to have a successful business.

Scam Events for Marcus Evans
Register for one of the next anti-scam events for Marcus Evans and learn about ethical corporate culture.

IFL
IFL are leaders in the Chrome industry. To find out more visit www.ifml.com